OB Mobile Logo

Search form


Anna Azvolinsky

Anna Azvolinsky

Freelance science writer and frequent Cancer Network and OncoTherapy Network contributor.

Follow Her on Twitter

Posts by Author

The risk of early, sudden-onset menopause in women treated for early-stage breast cancer can be reduced with goserelin, a gonadotropin-releasing hormone agonist.

Drinking coffee multiple times a day may decrease the risk of endometrial cancer in women, according to a new study.

A history of hormonal contraceptive use in younger women for 5 years or more was found to be associated with a possible increased risk of glioma.

Women with metabolic syndrome who are age 65 or older have an increased risk of endometrial cancer, according to the results of a new study.

A new human papillomavirus (HPV) vaccine that protects against nine types of HPV and would protect against about 90% of cervical cancers could be available in 2015.

Maintenance therapy with pazopanib improved progression-free survival by 5.6 months in advanced ovarian cancer patients, according to results of a new study.

A large trial found that men with moderate baldness at age 45 had an increased risk of developing aggressive prostate cancer compared with men with no baldness.

Researchers found that uterine cancers were present in 27 per 10,000 women undergoing morcellation, which fragments the uterus and can spread cancer cells.

A new study shows that people with high levels of the 15-PGDH enzyme who used aspirin regularly were half as likely to be diagnosed with colorectal cancer.

At the 1-day Cancer Immunotherapy: A Long Awaited Reality Conference, representatives from biotechnology companies and research clinicians working on immunotherapies discussed the promise of combination immunotherapies in cancer.


By clicking Accept, you agree to become a member of the UBM Medica Community.